Evidence map›Paper›PMID 20132445›Full record

ArticleMolecular microbiology2010

AcrA suppressor alterations reverse the drug hypersensitivity phenotype of a TolC mutant by inducing TolC aperture opening.

Jon W Weeks, Teresa Celaya-Kolb, Sara Pecora, Rajeev Misra

Open access · greenAbstract read
In one paragraph

Article in Molecular microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Suppressor Mutations inJournal of bacteriology · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Structural basis of RND-type multidrug exporters.Frontiers in microbiology · 2015
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jon W WeeksFaculty of Cellular and Molecular Biosciences, School of Life Sciences, Arizona State University, Tempe, AZ, USA.
Teresa Celaya-Kolb
Sara Pecora
Rajeev Misra
Arizona State University · US

Funding

Export &Import of Lethal Agents Mediated by TolCR01GM066988 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MISRA, RAJEEV · 2003 to 2006
$881k
NIGMS NIH HHS R01 GM066988NIGMS NIH HHS R01-GM066988
6 · The paper itself

Abstract

In Escherichia coli, the TolC-AcrAB complex forms a major antibiotic efflux system with broad substrate specificity. During the complex assembly, the periplasmic helices and bottom turns of TolC are thought to interact with a hairpin helix of AcrA and hairpin loops of AcrB respectively. In the present study we show that a four-residue substitution in TolC's turn 1, which connects outer helices 3 and 4 proximal to TolC's periplasmic aperture, confers antibiotic hypersensitivity, without affecting TolC-mediated phage or colicin infection. However, despite the null-like drug sensitivity phenotype, chemical cross-linking analysis revealed no apparent defects in the ability of the mutant TolC protein to physically interact with AcrA and AcrB. A role for TolC turn 1 residues in the functional assembly of the tripartite efflux pump complex was uncovered through isolating suppressor mutations of the mutant TolC protein that mapped within acrA and by utilizing a labile AcrA protein. The data showed that AcrA-mediated suppression of antibiotic sensitivity was achieved by dilating the TolC aperture/channel in an AcrB-dependent manner. The results underscore the importance of the periplasmic turn 1 of TolC in the functional assembly of the tripartite efflux complex and AcrA in transitioning TolC from its closed to open state.

Indexed as

Amino Acid SubstitutionAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBacteriophagesColicinsEscherichia coliEscherichia coli ProteinsLipoproteinsMembrane Transport ProteinsModels, BiologicalModels, MolecularMutant ProteinsProtein Structure, TertiarySuppression, GeneticVirus AttachmentAcrA protein, E coliAnti-Bacterial AgentsBacterial Outer Membrane ProteinsColicinsEscherichia coli ProteinsLipoproteinsMembrane Transport ProteinsMutant ProteinstolC protein, E coli

Identifiers

PMID20132445
PMCPMC2875072
OpenAlexW2072211742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.